Novel imaging method allows researchers to view strokes on a molecular level

New research led by scientists at the University of Missouri School of Medicine could accelerate stroke care by using imaging to track enzyme formation inside the brains of stroke victims in real-time, according to results of a study recently published in the Journal of Cerebral Blood Flow and Metabolism.

Ischemic strokes, which occur when a blocked artery prevents blood from getting to the brain, account for nearly 90 percent of all strokes, according to the American Heart Association. Research has shown this type of blockage to be associated with an activity spike in certain enzymes at the point of obstruction within the brain, according to lead author and associate professor Zezong Gu, PhD.

"During an ischemic stroke, harmful enzymes called gelatinase become overactive in areas of the brain where blood flow is cut off," Gu said in a university press release. "Over-activation of these enzymes causes brain damage. Our team hypothesized that if we could visualize and track this activity in real-time, we could then work on developing a way to block the activity and prevent brain damage from occurring."

Zu and his fellow researchers used peptides tagged with contrast agents designed specifically to recognize and track gelatinase activity, allowing them to view ischemic strokes in both cell and mouse models in real-time.

"Once the tagged peptides traveled to the site of increased gelatinase activity, they were absorbed into the cells with this activated enzyme," Gu said. "When enough of these peptides were absorbed, the stroke site was visible on an MRI. Using this method, we successfully tracked gelatinase activity."

The research could lead to dramatic improvements in the timeliness and effectiveness of stroke treatments and reduce the human impact of the damage caused by ischemic stroke.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Trimed Popup
Trimed Popup